Cost Analyses in the US and Japan: A Cross-Country Comparative Analysis Applied to the PRONOUNCE Trial in Non-Squamous Non-Small Cell Lung Cancer

por Hess, Lisa M., Rajan, Narayan, Winfree, Katherine, Davey, Peter, Ball, Mark, Knox, Hediyyih, Graham, Christopher
Publicado 2015

A cost-effectiveness analysis of first-line induction and maintenance treatment sequences in patients with advanced nonsquamous non-small-cell lung cancer in France

por Taipale, Kaisa, Winfree, Katherine B, Boye, Mark, Basson, Mickael, Sleilaty, Ghassan, Eaton, James, Evans, Rachel, Chouaid, Christos
Publicado 2017

A comprehensive review of nongenetic prognostic and predictive factors influencing the heterogeneity of outcomes in advanced non-small-cell lung cancer

por Cuyún Carter, Gebra, Barrett, Amy M, Kaye, James A, Liepa, Astra M, Winfree, Katherine B, John, William J
Publicado 2014

Real-World Treatment Sequences and Outcomes Among Patients With Non-Small Cell Lung Cancer (RESOUNDS) in the United States: Study Protocol

por Hess, Lisa M, Kern, David M, Carter, Gebra Cuyun, Winfree, Katherine, Wang, Liya, Sontag, Angelina, Oton, Ana B
Publicado 2017

Data Integration to Improve Real-world Health Outcomes Research for Non–Small Cell Lung Cancer in the United States: Descriptive and Qualitative Exploration

por Grabner, Michael, Molife, Cliff, Wang, Liya, Winfree, Katherine B, Cui, Zhanglin Lin, Cuyun Carter, Gebra, Hess, Lisa M
Publicado 2021

Patient Characteristics, Testing and Treatment Patterns, and Outcomes in EGFR-Mutated Advanced Non-Small Cell Lung Cancer: A Multinational, Real-World Study

por Molife, Cliff, Winfree, Katherine B., Bailey, Hollie, D’yachkova, Yulia, Forshaw, Cameron, Kim, Sangmi, Taipale, Kaisa-Leena, Puri, Tarun
Publicado 2023

Reweighting Randomized Controlled Trial Evidence to Better Reflect Real Life – A Case Study of the Innovative Medicines Initiative

por Happich, Michael, Brnabic, Alan, Faries, Douglas, Abrams, Keith, Winfree, Katherine B., Girvan, Allicia, Jonsson, Pall, Johnston, Joseph, Belger, Mark
Publicado 2020

Healthcare resource utilization in advanced non-small-cell lung cancer: post hoc analysis of the randomized phase 3 REVEL study

por Garon, Edward B., Winfree, Katherine B., Molife, Cliff, Cui, Zhanglin Lin, Arriola, Edurne, Levy, Benjamin, Mekhail, Tarek, Pérol, Maurice
Publicado 2020

Relative efficacy of interventions in the treatment of second-line non-small cell lung cancer: a systematic review and network meta-analysis

por Vickers, Adrian D., Winfree, Katherine B., Cuyun Carter, Gebra, Kiiskinen, Urpo, Jen, Min-Hua, Stull, Donald, Kaye, James A., Carbone, David P.
Publicado 2019

Treatment Decisions for Advanced Non-Squamous Non-Small Cell Lung Cancer: Patient and Physician Perspectives on Maintenance Therapy

por McMullen, Suzanne, Hess, Lisa M., Kim, Edward S., Levy, Benjamin, Mohamed, Mohamed, Waterhouse, David, Wozniak, Antoinette, Goring, Sarah, Müller, Kerstin, Muehlenbein, Catherine, Aggarwal, Himani, Zhu, Yajun, Oton, Ana B., Ersek, Jennifer L., Winfree, Katherine B.
Publicado 2018

PRONOUNCE: Randomized, Open-Label, Phase III Study of First-Line Pemetrexed + Carboplatin Followed by Maintenance Pemetrexed versus Paclitaxel + Carboplatin + Bevacizumab Followed...

por Zinner, Ralph G., Obasaju, Coleman K., Spigel, David R., Weaver, Robert W., Beck, J. Thaddeus, Waterhouse, David M., Modiano, Manuel R., Hrinczenko, Borys, Nikolinakos, Petros G., Liu, Jingyi, Koustenis, Andrew G., Winfree, Katherine B., Melemed, Symantha A., Guba, Susan C., Ortuzar, Waldo I., Desaiah, Durisala, Treat, Joseph A., Govindan, Ramaswamy, Ross, Helen J.
Publicado 2015